ICS/LABA combination dominates Australian asthma treatment
By Tony James
11 Aug 2017
Australians using an inhaled corticosteroid for asthma are almost twice as likely as New Zealanders to take it in combination with a long-acting beta agonist but disease control is equally poor in both countries, new research has shown. The study from the Woolcock Institute found that 61% of Australians used an ICS-containing inhaler compared to ...